{"id":"https://openalex.org/W7093560979","doi":null,"title":"\u041a\u0410\u0420\u0414\u0418\u041e\u041f\u0420\u041e\u0422\u0415\u041a\u0422\u0418\u0412\u041d\u042b\u0419 \u041f\u041e\u0422\u0415\u041d\u0426\u0418\u0410\u041b \u0418\u041d\u0413\u0418\u0411\u0418\u0422\u041e\u0420\u041e\u0412 \u041d\u0410\u0422\u0420\u0418\u0419-\u0413\u041b\u042e\u041a\u041e\u0417\u041d\u041e\u0413\u041e \u041a\u041e\u0422\u0420\u0410\u041d\u0421\u041f\u041e\u0420\u0422\u0415\u0420\u0410 (\u0424\u041e\u041a\u0423\u0421 \u041d\u0410 \u042d\u041c\u041f\u0410\u0424\u041b\u0418\u0424\u041b\u041e\u0417\u0418\u041d)","display_name":"\u041a\u0410\u0420\u0414\u0418\u041e\u041f\u0420\u041e\u0422\u0415\u041a\u0422\u0418\u0412\u041d\u042b\u0419 \u041f\u041e\u0422\u0415\u041d\u0426\u0418\u0410\u041b \u0418\u041d\u0413\u0418\u0411\u0418\u0422\u041e\u0420\u041e\u0412 \u041d\u0410\u0422\u0420\u0418\u0419-\u0413\u041b\u042e\u041a\u041e\u0417\u041d\u041e\u0413\u041e \u041a\u041e\u0422\u0420\u0410\u041d\u0421\u041f\u041e\u0420\u0422\u0415\u0420\u0410 (\u0424\u041e\u041a\u0423\u0421 \u041d\u0410 \u042d\u041c\u041f\u0410\u0424\u041b\u0418\u0424\u041b\u041e\u0417\u0418\u041d)","alternate_titles":[],"publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W7093560979"},"language":"ru","primary_location":{"id":"pmh:https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin","doi":null,"is_oa":true,"landing_page_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin","pdf_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin/pdf","source":{"id":"https://openalex.org/S4210185155","display_name":"Complex Issues of Cardiovascular Diseases","issn_l":"2306-1278","issn":["2306-1278","2587-9537"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4404678619","host_organization_name":"NII KPSSZ","host_organization_lineage":["https://openalex.org/P4404678619"],"host_organization_lineage_names":["NII KPSSZ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7093560979"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004772935","display_name":"\u0421\u0430\u0431\u0438\u0440\u043e\u0432 \u0418\u0431\u0440\u0430\u0433\u0438\u043c \u0421\u0430\u043c\u0438\u0436\u043e\u043d\u043e\u0432\u0438\u0447","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0421\u0430\u0431\u0438\u0440\u043e\u0432 \u0418.\u0421.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"\u041c\u0443\u0440\u043a\u0430\u043c\u0438\u043b\u043e\u0432 \u0418.\u0422.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u041c\u0443\u0440\u043a\u0430\u043c\u0438\u043b\u043e\u0432 \u0418.\u0422.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"\u0424\u043e\u043c\u0438\u043d \u0412.\u0412.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u0424\u043e\u043c\u0438\u043d \u0412.\u0412.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.890999972820282},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.48399999737739563},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8889999985694885},{"id":"https://openalex.org/keywords/empa-reg-outcome","display_name":"EMPA-REG OUTCOME","score":0.824999988079071},{"id":"https://openalex.org/keywords/glucose-excretion","display_name":"glucose excretion","score":0.7549999952316284},{"id":"https://openalex.org/keywords/insulin-independent-glucose-lowering","display_name":"insulin-independent glucose lowering","score":0.5920000076293945},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.33899998664855957}],"concepts":[{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.19869999587535858},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.19499999284744263},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1906999945640564},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.1860000044107437},{"id":"https://openalex.org/C18762648","wikidata":"https://www.wikidata.org/wiki/Q42213","display_name":"Work (physics)","level":2,"score":0.18389999866485596},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.16850000619888306},{"id":"https://openalex.org/C177264268","wikidata":"https://www.wikidata.org/wiki/Q1514741","display_name":"Set (abstract data type)","level":2,"score":0.16580000519752502},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.16410000622272491},{"id":"https://openalex.org/C2776608160","wikidata":"https://www.wikidata.org/wiki/Q4785462","display_name":"Natural (archaeology)","level":2,"score":0.16120000183582306},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.15870000422000885}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin","doi":null,"is_oa":true,"landing_page_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin","pdf_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin/pdf","source":{"id":"https://openalex.org/S4210185155","display_name":"Complex Issues of Cardiovascular Diseases","issn_l":"2306-1278","issn":["2306-1278","2587-9537"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4404678619","host_organization_name":"NII KPSSZ","host_organization_lineage":["https://openalex.org/P4404678619"],"host_organization_lineage_names":["NII KPSSZ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"}],"best_oa_location":{"id":"pmh:https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin","doi":null,"is_oa":true,"landing_page_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin","pdf_url":"https://cyberleninka.ru/article/n/kardioprotektivnyy-potentsial-ingibitorov-natriy-glyukoznogo-kotransportera-fokus-na-empafliflozin/pdf","source":{"id":"https://openalex.org/S4210185155","display_name":"Complex Issues of Cardiovascular Diseases","issn_l":"2306-1278","issn":["2306-1278","2587-9537"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4404678619","host_organization_name":"NII KPSSZ","host_organization_lineage":["https://openalex.org/P4404678619"],"host_organization_lineage_names":["NII KPSSZ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7093560979.pdf","grobid_xml":"https://content.openalex.org/works/W7093560979.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1505433241","https://openalex.org/W2013448178","https://openalex.org/W2032490123","https://openalex.org/W2034132952","https://openalex.org/W2048306990","https://openalex.org/W2104044832","https://openalex.org/W2127117939","https://openalex.org/W2136542175","https://openalex.org/W2138173919","https://openalex.org/W2146264128","https://openalex.org/W2148513135","https://openalex.org/W2150959326","https://openalex.org/W2153839551","https://openalex.org/W2154067841","https://openalex.org/W2157405334","https://openalex.org/W2162728371","https://openalex.org/W2235343273","https://openalex.org/W2257723432","https://openalex.org/W2282595618","https://openalex.org/W2297966562","https://openalex.org/W2306356166","https://openalex.org/W2555704326","https://openalex.org/W2592311396","https://openalex.org/W2593543484","https://openalex.org/W2608794164","https://openalex.org/W2610519768","https://openalex.org/W2618856448","https://openalex.org/W2763921543","https://openalex.org/W2801815064","https://openalex.org/W2883226358","https://openalex.org/W2888544493","https://openalex.org/W2889465766","https://openalex.org/W2897770807","https://openalex.org/W2899764361","https://openalex.org/W2903431537","https://openalex.org/W2915142973","https://openalex.org/W2919368874","https://openalex.org/W2967006081","https://openalex.org/W2972869264","https://openalex.org/W2974260792","https://openalex.org/W2986251343","https://openalex.org/W2989625789","https://openalex.org/W3010434992","https://openalex.org/W3011186745","https://openalex.org/W3081830235","https://openalex.org/W3090669482","https://openalex.org/W3201852810"],"related_works":["https://openalex.org/W3010434992","https://openalex.org/W7165256400","https://openalex.org/W3201852810","https://openalex.org/W7202377612","https://openalex.org/W7217083444","https://openalex.org/W4410745307","https://openalex.org/W7172244526","https://openalex.org/W4406171129","https://openalex.org/W4409602050","https://openalex.org/W7202177955"],"abstract_inverted_index":{"\u041e\u0431\u0437\u043e\u0440":[0],"\u043b\u0438\u0442\u0435\u0440\u0430\u0442\u0443\u0440\u044b":[1,122],"\u043f\u043e\u0441\u0432\u044f\u0449\u0435\u043d":[2],"\u043a\u0430\u0440\u0434\u0438\u043e\u043f\u0440\u043e\u0442\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u043c":[3],"\u0432\u043e\u0437\u043c\u043e\u0436\u043d\u043e\u0441\u0442\u044f\u043c":[4],"\u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u0438\u0442\u0435\u043b\u0435\u0439":[5],"\u043d\u043e\u0432\u043e\u0433\u043e":[6],"\u043a\u043b\u0430\u0441\u0441\u0430":[7],"\u0430\u043d\u0442\u0438\u0433\u0438\u043f\u0435\u0440\u0433\u043b\u0438\u043a\u0435\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445":[8],"\u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u043e\u0432":[9],"-":[10,90,92],"\u0438\u043d\u0433\u0438\u0431\u0438\u0442\u043e\u0440\u043e\u0432":[11,41,88,119],"\u043d\u0430\u0442\u0440\u0438\u0439-\u0433\u043b\u044e\u043a\u043e\u0437\u043d\u043e\u0433\u043e":[12],"\u043a\u043e\u0442\u0440\u0430\u043d\u0441\u043f\u043e\u0440\u0442\u0435\u0440\u0430":[13],"2-\u0433\u043e":[14,98],"\u0442\u0438\u043f\u0430":[15,99],"(SGLT2),":[16],"\u043a\u043e\u0442\u043e\u0440\u044b\u0435":[17],"\u0443\u043b\u0443\u0447\u0448\u0430\u044e\u0442":[18],"\u0433\u043b\u0438\u043a\u0435\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0439":[19],"\u043a\u043e\u043d\u0442\u0440\u043e\u043b\u044c":[20],"\u043f\u0443\u0442\u0435\u043c":[21],"\u0438\u043d\u0441\u0443\u043b\u0438\u043d\u043e\u043d\u0435\u0437\u0430\u0432\u0438\u0441\u0438\u043c\u043e\u0433\u043e":[22],"\u043c\u0435\u0445\u0430\u043d\u0438\u0437\u043c\u0430":[23],"\u0434\u0435\u0439\u0441\u0442\u0432\u0438\u044f,":[24],"\u0441\u0432\u044f\u0437\u0430\u043d\u043d\u043e\u0433\u043e":[25],"\u0441":[26,30,45,95],"\u0443\u0432\u0435\u043b\u0438\u0447\u0435\u043d\u0438\u0435\u043c":[27],"\u044d\u043a\u0441\u043a\u0440\u0435\u0446\u0438\u0438":[28],"\u0433\u043b\u044e\u043a\u043e\u0437\u044b":[29],"\u043c\u043e\u0447\u043e\u0439.":[31],"\u0412":[32,104],"\u0441\u0442\u0430\u0442\u044c\u0435":[33,105],"\u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d\u044b":[34],"\u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b":[35,77],"\u043a\u0440\u0443\u043f\u043d\u043e\u043c\u0430\u0441\u0448\u0442\u0430\u0431\u043d\u044b\u0445":[36],"\u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445":[37],"\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439":[38,109],"\u043f\u043e":[39,83],"\u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044e":[40],"SGLT2":[42,89],"\u0443":[43,93],"\u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432":[44,94],"\u0441\u0430\u0445\u0430\u0440\u043d\u044b\u043c":[46,96],"\u0434\u0438\u0430\u0431\u0435\u0442\u043e\u043c":[47,97],"\u0438":[48,100],"\u0431\u0435\u0437":[49],"\u043d\u0435\u0433\u043e,":[50],"\u0430":[51],"\u0442\u0430\u043a\u0436\u0435":[52],"\u0443\u0441\u0442\u0430\u043d\u043e\u0432\u043b\u0435\u043d\u043d\u044b\u043c\u0438":[53],"\u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u043c\u0438":[54,102],"\u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u043c\u0438":[55],"\u0438\u043b\u0438":[56],"\u043c\u043d\u043e\u0436\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u043c\u0438":[57],"\u0444\u0430\u043a\u0442\u043e\u0440\u0430\u043c\u0438":[58],"\u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u043e\u0433\u043e":[59],"\u0440\u0438\u0441\u043a\u0430.":[60],"\u041e\u043f\u0438\u0441\u0430\u043d":[61],"\u0440\u044f\u0434":[62],"\u043d\u0430\u0438\u0431\u043e\u043b\u0435\u0435":[63],"\u0447\u0430\u0441\u0442\u043e":[64],"\u043e\u0431\u0441\u0443\u0436\u0434\u0430\u0435\u043c\u044b\u0445":[65],"\u043a\u0430\u0440\u0434\u0438\u043e\u0441\u043f\u0435\u0446\u0438\u0444\u0438\u0447\u0435\u0441\u043a\u0438\u0445":[66],"\u043c\u0435\u0445\u0430\u043d\u0438\u0437\u043c\u043e\u0432,":[67],"\u043e\u043f\u043e\u0441\u0440\u0435\u0434\u043e\u0432\u0430\u043d\u043d\u044b\u0445":[68],"\u0438\u043d\u0433\u0438\u0431\u0438\u0442\u043e\u0440\u043e\u043c":[69],"SGLT2,":[70],"\u0432\u043b\u0438\u044f\u044e\u0449\u0438\u043c":[71],"\u043d\u0430":[72],"\u0441\u043e\u0441\u0442\u043e\u044f\u043d\u0438\u0435":[73],"\u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u043e\u0439":[74],"\u0441\u0438\u0441\u0442\u0435\u043c\u044b.":[75],"\u0418\u0437\u043b\u043e\u0436\u0435\u043d\u044b":[76],"\u043f\u043b\u0430\u0446\u0435\u0431\u043e-\u043a\u043e\u043d\u0442\u0440\u043e\u043b\u0438\u0440\u0443\u0435\u043c\u043e\u0433\u043e":[78],"\u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e":[79],"\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f":[80],"EMPA-REG":[81],"OUTCOME":[82],"\u0438\u0437\u0443\u0447\u0435\u043d\u0438\u044e":[84],"\u043a\u0430\u0440\u0434\u0438\u043e\u043f\u0440\u043e\u0442\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0445":[85],"\u0432\u043e\u0437\u043c\u043e\u0436\u043d\u043e\u0441\u0442\u0435\u0439":[86],"\u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u0438\u0442\u0435\u043b\u044f":[87],"\u044d\u043c\u043f\u0430\u0433\u043b\u0438\u0444\u043b\u043e\u0437\u0438\u043d\u0430":[91],"\u0441\u043e\u043f\u0443\u0442\u0441\u0442\u0432\u0443\u044e\u0449\u0438\u043c\u0438":[101],"\u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u043c\u0438.":[103],"\u043f\u043e\u0434\u0447\u0435\u0440\u043a\u043d\u0443\u0442\u0430":[106],"\u0432\u0430\u0436\u043d\u043e\u0441\u0442\u044c":[107],"\u0434\u0430\u043b\u044c\u043d\u0435\u0439\u0448\u0438\u0445":[108],"\u0434\u043b\u044f":[110],"\u0443\u0441\u0442\u0430\u043d\u043e\u0432\u043b\u0435\u043d\u0438\u044f":[111],"\u0441\u0442\u0435\u043f\u0435\u043d\u0438":[112],"\u0432\u043a\u043b\u0430\u0434\u0430":[113],"\u0432\u044b\u0448\u0435\u043f\u0435\u0440\u0435\u0447\u0438\u0441\u043b\u0435\u043d\u043d\u044b\u0445":[114],"\u043c\u0435\u0445\u0430\u043d\u0438\u0437\u043c\u043e\u0432":[115],"\u0432":[116,124],"\u043a\u0430\u0440\u0434\u0438\u043e\u043f\u0440\u043e\u0442\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0439":[117],"\u043f\u043e\u0442\u0435\u043d\u0446\u0438\u0430\u043b":[118],"SGLT2.":[120],"\u041f\u043e\u0438\u0441\u043a":[121],"\u0432\u044b\u043f\u043e\u043b\u043d\u0435\u043d":[123],"\u0431\u0430\u0437\u0435":[125],"\u0434\u0430\u043d\u043d\u044b\u0445":[126],"PubMed.":[127]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7093560979","counts_by_year":[],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2025-10-24T00:00:00"}
